newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics Appoints Ron Philip to Board of Directors

WAYNE, Pa., June 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical-stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated